E-LIB Suche - Ergebnisse für: Templeton, Ian

1

Effect of Hepatic Impairment on Cobimetinib Pharmacokinetic..:

Cheeti, Sravanthi ; Deng, Yuzhong ; Chang, Ilsung...
Clinical Pharmacology in Drug Development. 10 (2020) 2 - p. 144-152 , 2020

Link: https://doi.org/10.1002/..

2

A physiologically based pharmacokinetic modeling approach t..:

Templeton, Ian ; Ravenstijn, Paulien ; Sensenhauser, Carlo.
Biopharmaceutics & Drug Disposition. 37 (2016) 1 - p. 15-27 , 2016

Link: https://doi.org/10.1002/..

3

From the Bala Hissar to the Arg: How Royal Fortress Palaces..:

WOODBURN, BILL ; Templeton, Ian
The Court Historian. 17 (2012) 2 - p. 171-188 , 2012

Link: https://doi.org/10.1179/..

4

Novel Circular Grating Surface-Emitting Laser with Emission..:

Wu, Chunmeng ; Makino, Toshihiko ; Fallahi, Mahmoud...
Japanese Journal of Applied Physics. 33 (1994) 3B - p. L427 , 1994

Link: https://doi.org/10.1143/..

5

Physiologically Based Pharmacokinetic Modeling and Simulati..:

Chiang, Manting ; Sychterz, Caroline ; Perera, Vidya...
Clinical Pharmacology & Therapeutics. 114 (2023) 4 - p. 922-932 , 2023

Link: https://doi.org/10.1002/..

6

Evaluation of the Potential for Drug-Drug Interactions with..:

Bergagnini-Kolev, Mackenzie ; Kane, Katie ; Templeton, Ian E..
The AAPS Journal. 25 (2023) 4 - p. , 2023

Link: https://doi.org/10.1208/..

7

Creation of Novel Sensitive Probe Substrate and Moderate In..:

Templeton, Ian E. ; Rowland‐Yeo, Karen ; Jones, Hannah M....
Clinical Pharmacology & Therapeutics. 115 (2023) 2 - p. 299-308 , 2023

Link: https://doi.org/10.1002/..

8

Physiologically Based Pharmacokinetic Model Development and..:

Amore, Benny M. ; Patel, Nikunjkumar ; Batheja, Priya...
Pharmaceutics. 15 (2023) 5 - p. 1476 , 2023

Link: https://doi.org/10.3390/..

9

Pediatric Dose Selection and Utility of PBPK in Determining..:

Templeton, Ian E. ; Jones, Nicholas S. ; Musib, Luna
The AAPS Journal. 20 (2018) 2 - p. , 2018

Link: https://doi.org/10.1208/..

10

Pharmacokinetics of valerenic acid after administration of ..:

Anderson, Gail D. ; Elmer, Gary W. ; Kantor, Eric D...
Phytotherapy Research. 19 (2005) 9 - p. 801-803 , 2005

Link: https://doi.org/10.1002/..

11

MEK inhibitors beyond monotherapy: current and future devel..:

E Templeton, Ian ; Musib, Luna
Current Opinion in Pharmacology. 23 (2015) - p. 61-67 , 2015

Link: https://doi.org/10.1016/..

12

Effect of Hepatic Impairment on Cobimetinib Pharmacokinetic..:

Cheeti, Sravanthi ; Deng, Yuzhong ; Chang, Ilsung...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891419/. , 2020

Link: http://www.ncbi.nlm.nih...

13

Evaluation of 6β-hydroxycortisol, 6β-hydroxycortisone and t..:

Peng, Chi-Chi ; Templeton, Ian ; Thummel, Kenneth E...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3481835. , 2011

Link: http://www.ncbi.nlm.nih...

14

Contribution of Itraconazole Metabolites to Inhibition of C..:

Templeton, Ian ; Thummel, Kenneth E ; Kharasch, Evan D...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488349. , 2007

Link: http://www.ncbi.nlm.nih...

15

Physiologically Based Pharmacokinetic Model Development and..:

Amore, Benny M ; Patel, Nikunjkumar ; Batheja, Priya...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222242/. , 2023

Link: http://www.ncbi.nlm.nih...